Publication | Closed Access

p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target

Breast OncologyPd-l1 ExpressionImmunologyImmune Checkpoint InhibitorBreast CancerImmunotherapeuticsTumor SuppressorMicrorna DetectionMedicineCell BiologyTumor Biology